Welcure Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE331C01017
NSEID:
BSEID: 524661

INR

7.77

-0.15 (-1.89%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.16 k

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Mar'24

Dec'23

Sep'23

Jun'23

Mar'23

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2024 is -63.99% vs 0.00% in Sep 2024

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -77.72% vs 9,300.00% in Sep 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is -50.27% vs 3,800.00% in Sep 2024

Interest

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

Compare Quarterly Results Of Welcure Drugs With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

8.84

2,396.57

-2,387.73

-99.63%

Other Operating Income

0.00

Total Operating income

8.84

2,396.57

-2,387.73

-99.63%

Raw Material Cost

0.00

179.72

-179.72

-100.00%

Purchase of Finished goods

0.00

445.60

-445.60

-100.00%

(Increase) / Decrease In Stocks

7.38

34.08

-26.70

-78.35%

Employee Cost

0.11

521.79

-521.68

-99.98%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

0.43

474.45

-474.02

-99.91%

Total Expenditure (Excl Depreciation)

7.92

1,655.64

-1,647.72

-99.52%

Operating Profit (PBDIT) excl Other Income

0.92

740.93

-740.01

-99.88%

Other Income

0.00

69.82

-69.82

-100.00%

Operating Profit (PBDIT)

0.92

810.75

-809.83

-99.89%

Interest

0.00

199.47

-199.47

-100.00%

Exceptional Items

0.00

Gross Profit (PBDT)

0.92

611.28

-610.36

-99.85%

Depreciation

0.00

87.03

-87.03

-100.00%

Profit Before Tax

0.91

524.25

-523.34

-99.83%

Tax

0.50

107.87

-107.37

-99.54%

Provisions and contingencies

0.00

Profit After Tax

0.41

416.38

-415.97

-99.90%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

0.41

416.38

-415.97

-99.90%

Equity Capital

13.44

40.06

-26.62

-66.45%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.31

10.39

-10.08

-97.02%

Diluted Earnings per share

0.04

10.33

-10.29

-99.61%

Operating Profit Margin (Excl OI)

10.41%

30.92%

0.00

-20.51%

Gross Profit Margin

10.41%

25.51%

0.00

-15.10%

PAT Margin

4.64%

17.37%

0.00

-12.73%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 8.84 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -63.99% vs 0.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 0.41 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -77.72% vs 9,300.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 1,466.67% vs 0.00% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 0.92 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -50.27% vs 3,800.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 4,700.00% vs -100.00% in Dec 2023

Quarterly - Interest

No Interest in the last few periods

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 10.41%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023